Akanda Corp. (AKAN) Financials
AKAN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 36.5 million | 14.9 million |
| 2023-03-31 | 39.0 million | 12.1 million |
| 2022-12-31 | 43.5 million | 8.8 million |
| 2022-09-30 | ? | ? |
AKAN Free Cash Flow and Stock based compensation
No data available :(
AKAN Net Income
No data available :(
AKAN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 713338 | - | 245096 |
| 2023-03-31 | 492485 | - | - |
| 2022-12-31 | 4.3 million | - | 330821 |
| 2022-09-30 | - | - | - |
AKAN Shares Outstanding
AKAN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | 1935 | - | - | - |
| 2023-03-31 | 47555 | - | 3.8 million | 3.8 million |
| 2022-12-31 | 23777 | - | - | - |
| 2022-09-30 | 23777 | - | 3.8 million | 1.4 million |
AKAN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | 1.4 million | 4.2 million |
| 2023-03-31 | 2.5 million | 5.4 million |
| 2022-12-31 | - | - |
| 2022-09-30 | 1.3 million | 314835 |
AKAN
Price: $0.17
52 week price:
Earnings Per Share: -7.16 USD
P/E Ratio: -0.08
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Market Capitalization: 3.1 million